Sulfisoxazol (4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide) CAS:127-69-5

Sulfisoxazole is utilized in the treatment of bacterial infections, including urinary tract infections, respiratory tract infections, gastrointestinal infections, and certain sexually transmitted diseases. It demonstrates efficacy against a wide range of gram-positive and gram-negative bacteria, such as Escherichia coli, Streptococcus species, and Neisseria gonorrhoeae. Administration of sulfisoxazole is typically oral, with formulations available in tablets and suspension for convenient dosing. The dosage and duration of treatment vary based on the type and severity of the infection, as well as individual patient factors. Adherence to the prescribed regimen is crucial to achieve optimal therapeutic outcomes and minimize the risk of antibiotic resistance. Patients should be aware of potential side effects associated with sulfisoxazole therapy, including gastrointestinal disturbances, allergic reactions, and rare but serious adverse effects like Stevens-Johnson syndrome. Monitoring for adverse reactions during treatment and promptly reporting any unusual symptoms to healthcare providers are important precautions for safe and effective use of sulfisoxazole in bacterial infections. Consulting with healthcare professionals for personalized treatment recommendations and guidance on managing side effects is essential for optimal patient care.